Join to view full profile
1515 Holcombe BlvdHouston, TX 77030
Phone+1 713-792-6161
Fax+1 713-563-2366
Dr. Lin is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2005 - 2009
Loma Linda University Health Education ConsortiumInternship, Internal Medicine, 2004 - 2005
University of California, Irvine, School of MedicineClass of 2004
Certifications & Licensure
FL State Medical License 2021 - Present
AZ State Medical License 2023 - 2028
TN State Medical License 2023 - 2028
CA State Medical License 2006 - 2027
GA State Medical License 2023 - 2027
LA State Medical License 2023 - 2027
MS State Medical License 2023 - 2027
American Board of Radiology Radiation Oncology- Join now to see all
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ClinicStation, UT MD Anderson Cancer Center, 2013-2015
Clinical Trials
- Trimodality Management of T1b Esophageal Cancers
- A Phase II Study of Minocycline and Armodafinil for Reducing the Symptom Burden Produced by Chemoradiation Treatment for Esophageal Cancer
- Trametinib, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed by Surgery Start of enrollment: 2013 Oct 28
Publications & Presentations
PubMed
- 5 citationsFLASH Radiotherapy Mitigates Radiation-Induced Lymphopenia and Prevents Immunosuppression via Chk1-STAT3 Axis Modulation in a Preclinical Thoracic Irradiation Model.Rong-Hua Tao, Kevin Liu, Edgardo Aguilar, Min Wang, Sadhna Aggarwal
International Journal of Radiation Oncology, Biology, Physics. 2026-11-01 - Safety and Biomarker Analysis of NRG-LU004: Phase I Trial of Accelerated or Conventionally Fractionated Radiotherapy Combined With Durvalumab in PD-L1 High Locally Adv...Steven H Lin, Stephanie L Pugh, Diane Marie Del Valle, Vladimir Roudko, Martin J Edelman
International Journal of Radiation Oncology, Biology, Physics. 2026-09-12 - Phase 1a clinical trial of XRD-0394, a first-in-class dual ATM/DNA-PK inhibitor, in combination with palliative radiotherapy.Christopher T Chen, Michael F Gensheimer, Tona M Gilmer, Jennifer Stanley, Deborah Smith
International Journal of Radiation Oncology, Biology, Physics. 2026-09-11
Journal Articles
- Recurrence Risk Based on Pathologic Stage After Neoadjuvant Chemoradiotherapy in Esophageal Squamous Cell Carcinoma: Implications for Risk-Based Postoperative Surveill...Hong Yang, Steven H Lin, Annals of Surgical Oncology
- Does Proton Therapy Offer Demonstrable Clinical Advantages for Treating Thoracic Tumors?☆Zhongxing Liao, Saumil J Gandhi, Steven H Lin, ScienceDirect
Press Mentions
The Unexpected Ways Vaccines Could Boost Your HealthDecember 6th, 2025- Should Patients with Cancer Receive mRNA Vaccines Alongside Immunotherapy?November 21st, 2025
- COVID-19 Vaccines Have an Unexpected Side Effect: They Help the Immune System vs CancerOctober 29th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: